Malvern Instruments publishes new white paper on ‘Developing a bioformulation stability profile’

Malvern Instruments’ range of analytical solutions for the biopharmaceuticals industry focuses specifically on critical testing pathways and manufacturing requirements. As well as exhibiting solutions from its growing analytical toolbox at PepTalk 2014. Malvern will publish a new white paper that discusses the combined use of light scattering and microcapillary viscometry in the development of a bioformulation stability profile.

This new publication, ‘Developing a bioformulation stability profile’ is issued through Malvern’s Bioscience Development Initiative, which has been established to accelerate the innovation, development and promotion of novel technologies, products and capabilities to address unmet measurement needs in the bioscience arena.

Malvern’s analytical toolbox for biopharmaceutical development provides tried and trusted solutions as well as groundbreaking new technologies. Established systems include Viscotek size exclusion chromatographs for assessing product purity and the Zetasizer range for sizing and zeta potential analysis for product stability. New to the Malvern range are the Viscosizer 200, designed to assess bioformulation suitability and stability at points at the very beginning of development, together with Archimedes, Morphologi and the NanoSight ranges of instruments to quantify early aggregation and improve subvisible particle detection and identification in bioformulations.

http://j.mp/1cCqLSC

To learn more about Malvern’s Bioscience Development Initiative visit http://j.mp/1cCqKya

Malvern, Malvern Instruments, Morphologi, NanoSight, Viscotek and Zetasizer, are registered trademarks of Malvern Instruments Ltd